Literature DB >> 12176452

Chronic rejection and graft half-life: five-year follow-up of the European Tacrolimus Multicenter Renal Study.

A David Mayer1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12176452     DOI: 10.1016/s0041-1345(02)02942-1

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  7 in total

1.  Our experiences in kidney transplantation and monitoring of kidney graft outcomes.

Authors:  Rasić Senija; Dzemidzić Jasminka; Aganović Kenana; Aganović Damir; Prcić Alden
Journal:  Bosn J Basic Med Sci       Date:  2005-05       Impact factor: 3.363

Review 2.  Combating chronic renal allograft dysfunction : optimal immunosuppressive regimens.

Authors:  Pierre Merville
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 3.  Effect of immunosuppressive agents on long-term survival of renal transplant recipients: focus on the cardiovascular risk.

Authors:  Johannes M M Boots; Maarten H L Christiaans; Johannes P van Hooff
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 4.  Immunosuppression for long-term maintenance of renal allograft function.

Authors:  Gerd Offermann
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 5.  Tacrolimus: a further update of its use in the management of organ transplantation.

Authors:  Lesley J Scott; Kate McKeage; Susan J Keam; Greg L Plosker
Journal:  Drugs       Date:  2003       Impact factor: 9.546

6.  Tacrolimus confers lower acute rejection rates and better renal allograft survival compared to cyclosporine.

Authors:  Mahmoud Kamel; Manish Kadian; Titte Srinivas; David Taber; Maria Aurora Posadas Salas
Journal:  World J Transplant       Date:  2016-12-24

7.  Implication of interleukin-2 receptor antibody induction therapy in standard risk renal transplant in the tacrolimus era: a meta-analysis.

Authors:  Hatem Ali; Atif Mohiuddin; Ajay Sharma; Ihab Shaheen; Jon Jin Kim; Mohsen El Kosi; Ahmed Halawa
Journal:  Clin Kidney J       Date:  2019-01-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.